Where does Nfinium Vascular Technologies, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nfinium Vascular Technologies, LLC ranks #29,597 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nfinium Vascular Technologies, LLC hold?

Nfinium Vascular Technologies, LLC holds 9 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Nfinium Vascular Technologies, LLC's Innovation Score?

Nfinium Vascular Technologies, LLC has an Innovation Score of 45.0 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nfinium Vascular Technologies, LLC focus on?

Nfinium Vascular Technologies, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Nfinium Vascular Technologies, LLC's patent grant rate increasing or decreasing?

Nfinium Vascular Technologies, LLC's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nfinium Vascular Technologies, LLC's patents?

Nfinium Vascular Technologies, LLC's patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nfinium Vascular Technologies, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nfinium Vascular Technologies, LLC

USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nfinium ranks #29,597 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.

#29,597
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.0/100): 15.2
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29597 · US Corporation #29,597 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,597/49,997
PHOTO-FINISH NewMarket Pharmaceut…
CPC-NARROW A61B · 5 areas
INNOV-PAR 45.0/100
CLAIMS-RICH 15.2 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: NewMarket Pharmaceuticals LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nfinium’s 45.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (18%) Velocity 20.0 pts (44%) Breadth 7.9 pts (18%) Claim depth 9.1 pts (20%)

Qualcomm Incorporated · highest

85
Nfinium Vascular · this assignee

45
3D Lighting… · lowest

7

What this shows Nfinium's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nfinium?

Each dot is one of Nfinium’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nfinium’s own 15.2 claims/patent is at or below the 20.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Nfinium vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nfinium's grants concentrate

Nfinium Vascular Technologies, LLC is a focused PatentsView assignee: 5 CPC subclasses with 88.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Nfinium sits between NewMarket Pharmaceuticals LLC and Nimbus Saturn, Inc..

Nfinium's three-year grant acceleration

Nfinium Vascular Technologies, LLC shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Newmarket Pharmac…

9
Newsight Reality

9
Nexstim Oyj

9
Next Issue Media

9
Nightlight Systems

9
Nikola Motor

9
Nimbus Group

9
Nimbus Saturn

9
Nfinium Vascular ◀

9

What this shows Nfinium holds 9 patents at rank #29,604, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nfinium

By rank, the assignees closest to #29,604 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Nfinium's primary technology class.

Nfinium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Nfinium Vascular Technologies, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	11.1%
2017	1	11.1%
2018	1	11.1%
2019	1	11.1%
2022	1	11.1%
2023	1	11.1%
2024	1	11.1%
2025partial year	2	22.2%

Which technologies does Nfinium Vascular Technologies, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nfinium Vascular Technologies, LLC's patent record in context - here's where to go next.

Nfinium Vascular Technologies, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 88.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #29,597 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nfinium Vascular Technologies, LLC against NewMarket Pharmaceuticals LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.